UTHR UNITED THERAPEUTICS CORP DEL More: the full row for UNITED THERAPEUTICS CORP DEL Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,760,300 shares; 2025Q1: 2,675,000 shares; 2025Q2: 2,370,000 shares; 2025Q3: 2,022,222 shares; 2025Q4: 2,606,060 shares; 2026Q1: 2,630,000 shares; 2026Q2: 2,777,777 shares; 2026Q3: 2,755,555 shares 2,755,555 $1.49B 15.41% -22,222 Timeline ASND ASCENDIS PHARMA A/S More: the full row for ASCENDIS PHARMA A/S Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 5,111,111 shares; 2026Q3: 5,050,000 shares 5,050,000 $1.15B 11.87% -61,111 Timeline KRYS KRYSTAL BIOTECH INC More: the full row for KRYSTAL BIOTECH INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,628,822 shares; 2025Q1: 2,731,000 shares; 2025Q2: 2,660,000 shares; 2025Q3: 2,777,777 shares; 2025Q4: 2,888,888 shares; 2026Q1: 2,888,888 shares; 2026Q2: 2,888,888 shares; 2026Q3: 2,888,888 shares 2,888,888 $961M 9.91% 0 Timeline ARGX ARGENX SE More: the full row for ARGENX SE Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,238,467 shares; 2025Q1: 1,235,177 shares; 2025Q2: 1,175,000 shares; 2025Q3: 990,000 shares; 2025Q4: 990,000 shares; 2026Q1: 1,000,000 shares; 2026Q2: 1,000,000 shares; 2026Q3: 1,000,000 shares 1,000,000 $959M 9.89% 0 Timeline MDGL MADRIGAL PHARMACEUTICALS INC More: the full row for MADRIGAL PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,029,000 shares; 2025Q1: 2,022,222 shares; 2025Q2: 1,875,000 shares; 2025Q3: 1,833,000 shares; 2025Q4: 1,807,500 shares; 2026Q1: 1,818,181 shares; 2026Q2: 1,833,333 shares; 2026Q3: 1,833,333 shares 1,833,333 $924M 9.53% 0 Timeline KYMR KYMERA THERAPEUTICS INC More: the full row for KYMERA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 5,150,000 shares; 2025Q1: 6,460,000 shares; 2025Q2: 6,555,555 shares; 2025Q3: 6,350,000 shares; 2025Q4: 7,474,747 shares; 2026Q1: 7,474,747 shares; 2026Q2: 7,474,747 shares; 2026Q3: 7,474,747 shares 7,474,747 $836M 8.62% 0 Timeline ARWR ARROWHEAD PHARMACEUTICALS IN More: the full row for ARROWHEAD PHARMACEUTICALS IN Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 11,111,111 shares; 2025Q1: 11,111,111 shares; 2025Q2: 10,600,000 shares; 2025Q3: 10,900,000 shares; 2025Q4: 10,625,000 shares; 2026Q1: 10,699,999 shares; 2026Q2: 11,355,555 shares; 2026Q3: 11,000,000 shares 11,000,000 $720M 7.43% -355,555 Timeline RVMD REVOLUTION MEDICINES INC More: the full row for REVOLUTION MEDICINES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,170,000 shares; 2026Q1: 2,344,444 shares; 2026Q2: 2,297,000 shares; 2026Q3: 2,145,000 shares 2,145,000 $440M 4.54% -152,000 Timeline CYTK CYTOKINETICS INC More: the full row for CYTOKINETICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 3,333,333 shares; 2026Q2: 4,999,999 shares; 2026Q3: 4,900,000 shares 4,900,000 $323M 3.33% -99,999 Timeline DFTX DEFINIUM THERAPEUTICS INC More: the full row for DEFINIUM THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 5,000,000 shares; 2026Q2: 7,188,888 shares; 2026Q3: 7,050,000 shares 7,050,000 $268M 2.77% -138,888 Timeline GPCR STRUCTURE THERAPEUTICS INC More: the full row for STRUCTURE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 5,155,555 shares; 2025Q4: 6,555,555 shares; 2026Q1: 6,555,555 shares; 2026Q2: 6,555,555 shares; 2026Q3: 6,555,555 shares 6,555,555 $205M 2.12% 0 Timeline XENE XENON PHARMACEUTICALS INC More: the full row for XENON PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 5,666,666 shares; 2025Q1: 5,741,666 shares; 2025Q2: 5,400,000 shares; 2025Q3: 5,400,000 shares; 2025Q4: 5,424,444 shares; 2026Q1: 5,777,777 shares; 2026Q2: 5,777,777 shares; 2026Q3: 5,500,000 shares 5,500,000 $205M 2.11% -277,777 Timeline VERA VERA THERAPEUTICS INC More: the full row for VERA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 5,610,000 shares; 2025Q1: 5,701,900 shares; 2025Q2: 6,300,000 shares; 2025Q3: 6,210,000 shares; 2025Q4: 5,888,888 shares; 2026Q1: 5,888,888 shares; 2026Q2: 5,723,888 shares; 2026Q3: 5,635,000 shares 5,635,000 $182M 1.88% -88,888 Timeline QURE UNIQURE NV More: the full row for UNIQURE NV Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,175,000 shares; 2025Q1: 2,175,000 shares; 2025Q2: 3,625,000 shares; 2025Q3: 4,444,444 shares; 2025Q4: 6,150,000 shares; 2026Q1: 5,959,595 shares; 2026Q2: 6,727,777 shares; 2026Q3: 6,727,777 shares 6,727,777 $163M 1.68% 0 Timeline CELC CELCUITY INC More: the full row for CELCUITY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 3,111,111 shares; 2026Q1: 3,375,000 shares; 2026Q2: 3,400,000 shares; 2026Q3: 1,500,000 shares 1,500,000 $119M 1.23% -1,900,000 Timeline TSHA TAYSHA GENE THERAPIES INC More: the full row for TAYSHA GENE THERAPIES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 19,999,999 shares; 2025Q1: 19,999,999 shares; 2025Q2: 21,700,000 shares; 2025Q3: 21,700,000 shares; 2025Q4: 21,700,000 shares; 2026Q1: 21,700,000 shares; 2026Q2: 23,888,888 shares; 2026Q3: 23,888,888 shares 23,888,888 $116M 1.2% 0 Timeline OCUL OCULAR THERAPEUTIX INC More: the full row for OCULAR THERAPEUTIX INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 8,060,000 shares; 2025Q1: 8,060,000 shares; 2025Q2: 7,400,000 shares; 2025Q3: 10,250,000 shares; 2025Q4: 10,777,777 shares; 2026Q1: 12,315,000 shares; 2026Q2: 12,540,000 shares; 2026Q3: 12,380,300 shares 12,380,300 $95M 0.98% -159,700 Timeline DMRA DAMORA THERAPEUTICS INC More: the full row for DAMORA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 3,783,000 shares 3,783,000 $80.5M 0.83% new Timeline COAG HEMAB THERAPEUTICS HLDGS INC More: the full row for HEMAB THERAPEUTICS HLDGS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,925,150 shares; 2026Q3: 1,892,372 shares 1,892,372 $58.4M 0.6% -32,778 Timeline VRDN VIRIDIAN THERAPEUTICS INC More: the full row for VIRIDIAN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,500,000 shares; 2026Q1: 1,500,000 shares; 2026Q2: 2,500,000 shares; 2026Q3: 2,500,000 shares 2,500,000 $51.5M 0.53% 0 Timeline SEPN SEPTERNA INC More: the full row for SEPTERNA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,110,000 shares; 2025Q1: 1,337,500 shares; 2025Q2: 1,237,500 shares; 2025Q3: 1,337,500 shares; 2025Q4: 1,337,500 shares; 2026Q1: 1,337,500 shares; 2026Q2: 1,337,500 shares; 2026Q3: 1,300,000 shares 1,300,000 $50.9M 0.52% -37,500 Timeline ABVX ABIVAX SA More: the full row for ABIVAX SA Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 488,000 shares 488,000 $48.3M 0.5% new Timeline SCTX SCRIBE THERAPEUTICS INC More: the full row for SCRIBE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,598,973 shares 2,598,973 $47.8M 0.49% new Timeline FTH FAETH THERAPEUTICS INC More: the full row for FAETH THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,444,039 shares; 2026Q3: 1,410,000 shares 1,410,000 $41.9M 0.43% -34,039 Timeline GHRS GH RESEARCH PLC More: the full row for GH RESEARCH PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,800,000 shares; 2026Q1: 1,800,000 shares; 2026Q2: 1,800,000 shares; 2026Q3: 1,770,000 shares 1,770,000 $41.6M 0.43% -30,000 Timeline Biohaven Pharmaceutical Hol… Biohaven Pharmaceutical Holding C… More: the full row for Biohaven Pharmaceutical Holding Co. Ltd Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,750,000 shares 2,750,000 $36.7M 0.38% new AVTX AVALO THERAPEUTICS INC More: the full row for AVALO THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,410,000 shares; 2026Q2: 2,333,333 shares; 2026Q3: 2,377,777 shares 2,377,777 $36.5M 0.38% +44,444 Timeline BRVE BRAVEHEART BIO INC More: the full row for BRAVEHEART BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,255,000 shares 1,255,000 $25.4M 0.26% new Timeline WHWK WHITEHAWK THERAPEUTICS INC More: the full row for WHITEHAWK THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,849,402 shares; 2025Q1: 2,849,402 shares; 2025Q2: 2,849,402 shares; 2025Q3: 2,849,402 shares; 2025Q4: 2,849,402 shares; 2026Q1: 2,849,402 shares; 2026Q2: 2,849,402 shares; 2026Q3: 2,849,402 shares 2,849,402 $10.7M 0.11% 0 Timeline LXEO LEXEO THERAPEUTICS INC More: the full row for LEXEO THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 3,300,000 shares; 2026Q1: 1,875,000 shares; 2026Q2: 1,489,189 shares; 2026Q3: 525,000 shares 525,000 $1.77M 0.02% -964,189 Timeline